BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lovastatin
,
rs3825942
,
PTEN
,
calcium channel activity
,
Breast Cancer
,
Hypothalamus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
tumour</a> viruses
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for tumour</a> viruses
Explore Curated Studies Results
Literature
Most Relevant Literature
Isolated limb perfusion with melphalan, tumour necrosis factor-alpha and oncolytic vaccinia virus im…
Expression patterns of endogenous avian retrovirus ALVE1 and its response to infection with exogenou…
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes …
Modulation of DNA damage and repair pathways by human tumour viruses.
Tumour-inducing viruses.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
An Investigational Immuno-therapy Study to Investigate the Safety and Effectiveness of Nivolumab, an…
Safety and Effectiveness Study of G207, a Tumor-Killing Virus, in Patients With Recurrent Brain Canc…
Cabozantinib S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency Vir…
Recombinant Anti-tumor and Anti-virus Protein for Injection to Treat Advanced Neuroendocrine Tumors
Denosumab In Ebv Nasopharyngeal Carcinoma As A Model For RankMediated Immunologic Modulation Of Viru…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ